E
Lyell Immunopharma, Inc. LYEL
$0.5854 -$0.0209-3.45%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income -191.94M -44.58M -45.81M -60.67M -52.93M
Total Depreciation and Amortization 5.03M 4.68M 4.90M 5.02M 5.06M
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 139.63M 3.82M 3.77M 16.86M 5.52M
Change in Net Operating Assets 34.00K 1.04M -954.00K -3.24M 1.72M
Cash from Operations -47.24M -35.04M -38.09M -42.02M -40.64M
Capital Expenditure -44.00K -59.00K -331.00K -30.00K -25.00K
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -31.35M -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 84.90M 1.98M 45.34M 22.02M -100.67M
Cash from Investing 53.51M 1.92M 45.01M 21.99M -100.69M
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 437.00K 0.00 862.00K 103.00K 882.00K
Repurchase of Common Stock 0.00 0.00 0.00 -76.00K -123.00K
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 437.00K 0.00 862.00K 27.00K 759.00K
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 6.70M -33.12M 7.78M -20.00M -140.57M
Weiss Ratings